Clinical Trials at University of Vermont
As of September 2026, 22 paid clinical trials are recruiting at University of Vermont, located at UVM, PATRICK GYM, BURLINGTON, VT 05405-0117, phone (802) 656-7750 in Burlington, Vermont. Active studies at this site cover conditions such as Heart Failure, Acute Myeloid Leukemia and Anatomic Stage II Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
22 clinical trials at University of Vermont
·Clear filters·A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
Deep Functional Phenotyping of the ALA Lung Health Cohort
Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
His-Bundle Corrective Pacing in Heart Failure
Left vs Left Randomized Clinical Trial
Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Fatty Acid Modulation of Brain Function in Older Adults
PRESERVE & CONNECT: Impact Study of the BPC
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
LEMURS SSI: Evaluation of Behavioral Incentives
Common conditions studied in Burlington
- Heart Failure (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Cancer (3 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
Leading research sponsors in Burlington
- University of Vermont
- National Cancer Institute (NCI)
- University of Vermont Medical Center
- Children's Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Burlington?
There are approximately 160 recruiting clinical trials in Burlington, Vermont listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Burlington pay participants?
Most recruiting trials in Burlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Burlington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Burlington?
The most common conditions under active study in Burlington include Heart Failure (7), Acute Myeloid Leukemia (6), Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Burlington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Burlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Burlington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Burlington?
Recruiting research sites in Burlington include University of Vermont Medical Center, University of Vermont and State Agricultural College, University of Vermont, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Burlington right now?
The largest active categories in Burlington are Cancer & tumors (68), Cardiovascular (18), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Vermont?
University of Vermont is located at UVM, PATRICK GYM, BURLINGTON, VT 05405-0117. Use the Google Maps link in the intro above to get directions.
How do I contact University of Vermont?
You can reach University of Vermont by phone at (802) 656-7750. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.